Litigation in Obstetrics: a Lesson Learnt and a Lesson to Share
Article Outline
Summary
A perfect baby is the expectation of all parents, and a perfect outcome is the mission of obstetrics. Every obstetrician dreads to hear that there is an unexpected maternal mortality and/or severe fetal injury at the hospital. The role of a perceived public expectation of perfection in obstetric medicine reflects a belief that bad outcomes in obstetrics should not be tolerated and that every maternal-fetal injury merits financial compensation and punishment. What has brought these troubling times to obstetric medicine? The drivers behind malpractice crises are the four leading interest groups in the medical-legal debate: pregnant patients and their environment (husband, parents, relatives, friends, legislators, and the media), health-care providers, insurance companies, and trial attorneys. Litigation in obstetrics is the result of a complex of events when malpractice (presumed or real) impacts on the attitude of pregnant women and their environment. In such complexity, information is mandatory but may often be misinterpreted. If messages are not tailored to the receiver's capacity, communicating well with the pregnant patient becomes crucial. Therefore, to reduce medical-legal issues in obstetrics, increasing attention and an applicable standard of obstetric care to avoid negligence and medical errors should go along with better communication with pregnant women. Communication should be clear, targeted, effective, flexible, and empathic to share a common language and decisions. This review briefly presents and discusses some of the most frequently encountered medical-legal claim cases in obstetric practice. In-depth review of pregnancy-related deaths and major morbidities can help determine strategies needed to continue making pregnancy safer.
Key Words: litigation , malpractice , maternal mortality , obstetrics , pregnancy
No full text is available. To read the body of this article, please view the PDF online.
References
- . Pregnancy-related mortality surveillance-United States, 1991–1999 . MMWR Surveill Summ . 2003;52:1–8
- . Maternal mortality: confidential enquiries into maternal deaths in the United Kingdom . Am J Obstet Gynecol . 2000;182:760–766
- . Maternal deaths in an urban perinatal network, 1992–1998 . Am J Obstet Gynecol . 2000;183:1207–1212
- Preventability of pregnancy-related deaths: results of a state-wide reviews . Obstet Gynecol . 2005;106:1228–1234
- . Diagnosis of pulmonary embolism. A cost-effectiveness analysis . Am J Obstet Gynecol . 2004;191:1019–1023
- . Massive pulmonary embolisim in pregnancy treated with tissue plasminogen activator . Obstet Gynecol . 2005;106:1156–1158
- . Postcesarean pulmonary embolism, sustained cardiopulmonary resuscitation, embolectomy, and near-death experience . Obstet Gynecol . 2005;106:1153–1155
- . Massive pulmonary embolism in pregnancy treated with catheter fragmentation and local thrombolysis . Obstet Gynecol . 2005;106:1158–1160
- . Can more be done in obstetric and gynecologic practice to reduce morbidity and mortality associated with venous thromboembolism . Am J Obstet Gynecol . 1999;180:784–791
- . Maternal mortality: we must do better . Contemp Ob Gyn . 2002;1:10–14
- . Genetic susceptibility to venous thrombosis . N Engl J Med . 2001;344:1222–1231
- Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium . N Engl J Med . 2000;342:374–380
- . Preventing VTE: part 3-the pregnant patient . Contemp Ob Gyn . 2005; May 1.
- . Inherited thrombophilias in pregnant patients: detection and treatment paradigm . Obstet Gynecol . 2002;99:333–341
- . Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy . Am J Obstet Gynecol . 2005;193:859–863
- . Maternal morbidity and mortality in 442 pregnancies with hemlolysis, elevated liver enzymes and low platelets . Am J Obstet Gynecol . 1993;169:1000–1006
- . Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity . Am J Obstet Gynecol . 1999;180:1407–1414
- . Corticosteroids for HELLP syndrome in pregnancy . Cochrane Database Syst Rev . 2004; CD002076.
- . Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial . Am J Obstet Gynecol . 2005;193:1591–1598
- . Impact of high-dose corticosteroid therapy for patients with HELLP syndrome . Am J Obstet Gynecol . 2000;183:921–924
- . Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome . Am J Obstet Gynecol . 2003;189:830–834
- . Dexamethasone to improve maternal outcome in women with hemolysis, elevated liver enzymes, and low platelets syndrome . Am J Obstet Gynecol . 2005;193:1587–1590
- . Postpartum plasma exchange for atypical preeclampsiaeclampsia as HELLP syndrome . Am J Obstet Gynecol . 1995;172:1107–1127
- . Maternal mortality associated with HELLP syndrome . Am J Obstet Gynecol . 1999;181:924–928
- . Successful application of extracorporeal membrane oxygenation and intra-aortic balloon counterpulsation as lifesaving therapy for a patient with amniotic fluid embolism . Am J Obstet Gynecol . 2000;183:496–497
- . Amniotic fluid embolism: analysis of the national registry . Am J Obstet Gynecol . 1995;172:1158–1169
- . Amniotic fluid embolism, anaphylaxis and tryptase . Am J Obstet Gynecol . 1996;175:737–738
- . The syndrome of amniotic fluid embolism: a potential contribution of bradykinin . Am J Obstet Gynecol . 2005;193:1508–1512
- . Prenatal diagnosis and perinatal management of placenta previa accrea: past, present and future . Taiwanese J Obstet Gynecol . 2004;43:64–71
- . Prenatal diagnosis of placenta previa accreta by transabdominal color Doppler ultrasound . Ultrasound Obstet Gynecol . 2000;15:28–35
- . Three-dimensional color power Doppler imaging in the assessment of uteroplacental neovascularization in placenta previa incretapercreta . Am J Obstet Gynecol . 2001;185:1257–1261
- . Internal iliac artery embolization before hysterectomy for placenta accreta . J Vasc Interv Radiol . 2003;14:1195–1199
- . Ho ESC Usefulness of gray-scale ultrasound and complementary color Doppler ultrasound in the prenatal diagnosis of placenta previa accrete . Am J Obstet Gynecol . 2005;192:1349–1350
- . Experience with conservative strategy of uterine artery embolization in the treatment of placenta percreta in the first trimester of pregnancy . Taiwanese J Obstet Gynecol . 2006; (in press).
- . Maternal and perinatal complications with uterine rupture in 142,075 patients who attempted vaginal birth after cesarean delivery: a review of the literature . Am J Obstet Gynecol . 2003;189:408–417
- . Uterine rupture: risk factors and pregnancy outcome . Am J Obstet Gynecol . 2003;189:1042–1046
- Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery . N Engl J Med . 2004;351:2581–2589
- . Obstetric outcomes in women with two prior cesarean deliveries: is vaginal birth after cesarean delivery a viable option? . Am J Obstet Gynecol . 2005;192:1223–1228
- . Uterine rupture during induced or augmented labor in gravid women with one prior cesarean delivery . Am J Obstet Gynecol . 1999;181:882–886
- . Uterine rupture associated with misoprostol labor induction in women with previous cesarean delivery . Eur J Obstet Gynecol Reprod Biol . 2004;113:45–48
- . Sonographic measurement of the lower uterine segment thickness in women with previous caesarean section . J Obstet Gynaecol Can . 2005;27:674–681
- . Maternal death after second-trimester genetic amniocentesis . Obstet Gynecol . 2005;106:409
- . Maternal death after second-trimester genetic amniocentesis . Obstet Gynecol . 2005;105:1213–1215
- . Maternal mortality following diagnostic second-trimester amniocentesis . Fetal Diagn Ther . 2004;19:195–198
- . Fatal sepsis due to Escherichia coli after second-trimester amniocentesis . Fetal Diagn Ther . 1998;13:98–99
- . Septic shock in pregnancy . Obstet Gynecol . 1997;90:553–561
- . Treating septic shock in ob/gyn patients . Contemp Ob Gyn . 2005; May 1.
- . Shoulder dystocia: are historic risk factors reliable predictors? . Am J Obstet Gynecol . 2005;192:1933–1938
- Accuracy of estimated fetal weight in shoulder and neonatal birth injury . Am J Obstet Gynecol . 2005;192:1877–1881
- . Effects of a policy of elective cesarean delivery in cases of suspected fetal macrosomia on the incidence of brachial plexus injury and the rate of cesarean delivery . Am J Obstet Gynecol . 2000;183:1296–1300
- . A no-fault approach to shoulder dystocia . Contemp Ob Gyn . 2004; Dec. 1.
- . Brachial plexus palsy: an old problem revisited . Am J Obstel Gynecol . 1992;166:1673–1677
- . Who will deliver our grandchildren? Implications of cerebral palsy litigation . JAMA . 2005;294:1688–1690
- . Presidential address: Medical-legal issues in obstetrics and gynecology . Am J Obstet Gynecol . 2005;192:1883–1889
PII: S1028-4559(09)60183-2
doi:10.1016/S1028-4559(09)60183-2
© 2006 Taiwan Association of Obstetric & Gynecology. Published by Elsevier Inc. All rights reserved.
